Invitrogen™ SLC6A13 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5104149

Catalog No. PIPA5104149

Description

Antibody detects endogenous levels of total SLC6A13.

Slc6a13 catalyzes sodium and chloride dependent transport of gamma-aminobutyric acid (GABA) to terminate GABA mediated synaptic activity. Slc6a13 is also a high-affinity gamma-aminobutyric acid (GABA) transporter, terminates biological actions of GABA by reuptake into cell, and its reuptake function utilizes sodium and chloride concentration gradients. Further, Slc6a13 may also aid in beta-alanine transport. Diseases associated with SLC6A13 include Traumatic Glaucoma and Neovascular Glaucoma.

Specifications

• Antigen: SLC6A13
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: Slc6a13
• Gene Alias: GABA transport protein; GABA transporter 2; Gabt2; Gabt3; Gabt4; gamma-aminobutyric acid (GABA-A) transporter 3; GAT2; GAT-2; GAT3; Gat-3; Slc6a13; Sodium- and chloride-dependent GABA transporter 2; sodium- and chloride-dependent GABA transporter 3; solute carrier family 6 (neurotransmitter transporter), member 13; solute carrier family 6 (neurotransmitter transporter, GABA), member 13; solute carrier family 6 member 13
• Host Species: Rabbit
• Purification Method: Affinity Chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 14412, 171163, 6540
• Content And Storage: -20°C
• Form: Liquid

• Applications: Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry
• Concentration: 1 mg/mL
• Formulation: PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
• Gene Accession No.: P31646, P31649, Q9NSD5
• Gene Symbols: Slc6a13
• Immunogen: A synthesized peptide derived from human SLC6A13(Accession Q9NSD5), corresponding to amino acid residues S143-K193.
• Quantity: 100 μL
• Primary or Secondary: Primary
• Target Species: Human, Mouse, Rat
• Product Type: Antibody
• Isotype: IgG

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov